Nirhali Sonali Chandrakant

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Hi Tech BioSciences India (India)(Current)

Nirhali Sonali Chandrakant is an author at Hi Tech BioSciences India (India) specializing in immunoregulation, pharmacotherapy, and immunotherapy safety.

ORCID

Publications per year

2022–2022

Publications

A Double-blind Multicenter Two-arm Randomized Placebo-controlled Phase-III Clinical Study to Evaluate the Effectiveness and Safety of Thymosin α1 as an Add-on Treatment to Existing Standard of Care Treatment in Moderate-to-severe COVID-19 Patients

Adarsh Shetty, Nirhali Sonali Chandrakant, Rahul Darnule · Indian Journal of Critical Care Medicine · 2022 · 15 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +11

1–1 of 1